Peter Willeit
Peter Willeit
Medical University of Innsbruck and University of Cambridge
E-mail confirmado em cam.ac.uk - Página inicial
Título
Citado por
Citado por
Ano
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million …
L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ...
The Lancet 390 (10113), 2627-2642, 2017
17372017
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes
A Zampetaki, S Kiechl, I Drozdov, P Willeit, U Mayr, M Prokopi, A Mayr, ...
Circulation research 107 (6), 810-817, 2010
12332010
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ...
The Lancet 388 (10046), 776-786, 2016
8762016
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
IL6R Genetics Consortium Emerging Risk Factors Collaboration
The Lancet 379 (9822), 1205-1213, 2012
5442012
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
PC Haycock, EE Heydon, S Kaptoge, AS Butterworth, A Thompson, ...
Bmj 349, g4227, 2014
4772014
Telomere length and risk of incident cancer and cancer mortality
P Willeit, J Willeit, A Mayr, S Weger, F Oberhollenzer, A Brandstätter, ...
Jama 304 (1), 69-75, 2010
4292010
Prospective study on circulating MicroRNAs and risk of myocardial infarction
A Zampetaki, P Willeit, L Tilling, I Drozdov, M Prokopi, JM Renard, A Mayr, ...
Journal of the American College of Cardiology 60 (4), 290-299, 2012
3572012
Lipid-related markers and cardiovascular disease prediction
R Used
Jama 307 (2499), 506, 2012
3462012
Association of cardiometabolic multimorbidity with mortality
E Di Angelantonio, S Kaptoge, D Wormser, P Willeit, AS Butterworth, ...
Jama 314 (1), 52-60, 2015
3202015
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
AM Wood, S Kaptoge, AS Butterworth, P Willeit, S Warnakula, T Bolton, ...
The Lancet 391 (10129), 1513-1523, 2018
3152018
Cardioprotection and lifespan extension by the natural polyamine spermidine
T Eisenberg, M Abdellatif, S Schroeder, U Primessnig, S Stekovic, T Pendl, ...
Nature medicine 22 (12), 1428, 2016
2822016
Circulating microRNAs as novel biomarkers for platelet activation
P Willeit, A Zampetaki, K Dudek, D Kaudewitz, A King, NS Kirkby, ...
Circulation research 112 (4), 595-600, 2013
2642013
Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study
C Stegemann, R Pechlaner, P Willeit, SR Langley, M Mangino, U Mayr, ...
Circulation 129 (18), 1821-1831, 2014
2582014
Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk
P Willeit, J Willeit, A Brandstätter, S Ehrlenbach, A Mayr, A Gasperi, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (8), 1649-1656, 2010
2542010
Profiling of circulating microRNAs: from single biomarkers to re-wired networks
A Zampetaki, P Willeit, I Drozdov, S Kiechl, M Mayr
Cardiovascular research 93 (4), 555-562, 2012
2382012
Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay
S Ehrlenbach, P Willeit, S Kiechl, J Willeit, M Reindl, K Schanda, ...
International journal of epidemiology 38 (6), 1725-1734, 2009
1962009
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants
B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ...
The Lancet 389 (10064), 37-55, 2017
1912017
Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study
PC Haycock, S Burgess, A Nounu, J Zheng, GN Okoli, J Bowden, ...
JAMA oncology 3 (5), 636-651, 2017
1752017
Glycated hemoglobin measurement and prediction of cardiovascular disease
E Di Angelantonio, P Gao, H Khan, AS Butterworth, D Wormser, ...
Jama 311 (12), 1225-1233, 2014
1662014
Discrimination and net reclassification of cardiovascular risk with lipoprotein (a): prospective 15-year outcomes in the Bruneck Study
P Willeit, S Kiechl, F Kronenberg, JL Witztum, P Santer, M Mayr, Q Xu, ...
Journal of the American College of Cardiology 64 (9), 851-860, 2014
1632014
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20